BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 31638175)

  • 1. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
    Huang DH; Jian J; Li S; Zhang Y; Liu LZ
    Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
    Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma.
    Huang Y; Guo W; Kan H
    Int J Mol Sci; 2014 Oct; 15(10):18148-61. PubMed ID: 25302620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L; Zheng J; Chen P; Liu Q; Yuan Y
    Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway.
    Sui Y; Zheng X; Zhao D
    Tumour Biol; 2015 Nov; 36(11):8661-70. PubMed ID: 26044564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
    Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
    J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
    Wang J; Liu Z; Dou C; Han S; Li C; Tu K; Yang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):512-7. PubMed ID: 27053618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways.
    Liu Y; Qi Y; Bai ZH; Ni CX; Ren QH; Xu WH; Xu J; Hu HG; Qiu L; Li JZ; He ZG; Zhang JP
    Acta Pharmacol Sin; 2017 Jan; 38(1):120-132. PubMed ID: 27773936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
    Geng D; Zhao W; Feng Y; Liu J
    Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway.
    Yao Y; Dou C; Lu Z; Zheng X; Liu Q
    Cell Physiol Biochem; 2015; 35(3):983-96. PubMed ID: 25660117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells.
    Ye M; Li J; Gong J
    Oncol Rep; 2017 Jun; 37(6):3167-3174. PubMed ID: 28498423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 18. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of the Sonic Hedgehog (SHH) Gene Inhibits Proliferation of Hep3B and SMMC-7721 Hepatocellular Carcinoma Cells via the PI3K/Akt/PCK1 Signaling Pathway.
    Chen Y; Zhu W
    Med Sci Monit; 2019 Aug; 25():6023-6033. PubMed ID: 31406102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
    Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
    Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.